Rare variants in MC1R/TUBB3 exon 1 are not associated with Parkinson's disease

Affiliations

Comment

Oswaldo Lorenzo-Betancor et al. Ann Neurol. 2016 Feb.

. 2016 Feb;79(2):331.

doi: 10.1002/ana.24581. Epub 2016 Jan 19.

No abstract available

Conflict of interest statement

Potential Conflicts of Interest

There are no conflicts of interest.

The MC1R melanoma risk variant p.R160W is associated with Parkinson disease.
Tell-Marti G, Puig-Butille JA, Potrony M, Badenas C, Milà M, Malvehy J, Martí MJ, Ezquerra M, Fernández-Santiago R, Puig S. Tell-Marti G, et al. Ann Neurol. 2015 May;77(5):889-94. doi: 10.1002/ana.24373. Epub 2015 Mar 13. Ann Neurol. 2015. PMID: 25631192

1. Tell-Marti G, Puig-Butille JA, Potrony M, et al. The MC1R melanoma risk variant p.R160W is associated with Parkinson disease. Ann Neurol. 2015 May;77(5):889–894. - PubMed
1. Liu R, Gao X, Lu Y, Chen H. Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology. 2011 Jun 7;76(23):2002–2009. - PMC - PubMed
1. Ranganathan S, Dexter DW, Benetatos CA, Hudes GR. Cloning and sequencing of human betaIII-tubulin cDNA: induction of betaIII isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agents. Biochim Biophys Acta. 1998 Jan 21;1395(2):237–245. - PubMed
1. Dong J, Gao J, Nalls M, et al. Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease. Neurobiol Aging. 2014 Jun;35(6):1512 e5–1512 e10. - PMC - PubMed
1. Lubbe SJ, Escott-Price V, Brice A, et al. Is the MC1R variant p.R160W associated with Parkinson's? Ann Neurol. 2015 Sep 21; - PMC - PubMed